The estimated Net Worth of Mark Kessel is at least $30 millió dollars as of 16 October 2012. Mark Kessel owns over 6,000,000 units of Organovo Inc stock worth over $1,666,074 and over the last 20 years Mark sold ONVO stock worth over $28,380,000.
Mark has made over 1 trades of the Organovo Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Mark sold 6,000,000 units of ONVO stock worth $28,380,000 on 16 October 2012.
The largest trade Mark's ever made was selling 6,000,000 units of Organovo Inc stock on 16 October 2012 worth over $28,380,000. On average, Mark trades about 285,714 units every 0 days since 2004. As of 16 October 2012 Mark still owns at least 3,031,431 units of Organovo Inc stock.
You can see the complete history of Mark Kessel stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is 6275 NANCY RIDGE DRIVE, SUITE 110, , SAN DIEGO, CA, 92121.
Over the last 13 years, insiders at Organovo Inc have traded over $8,085,375 worth of Organovo Inc stock and bought 386,250 units worth $661,443 . The most active insiders traders include Mark Kessel, Keith Murphy és Adam K Stern. On average, Organovo Inc executives and independent directors trade stock every 112 days with the average trade being worth of $29,354. The most recent stock trade was executed by David Gobel on 15 November 2023, trading 19,607 units of ONVO stock currently worth $31,763.
organovo (nyse mkt: onvo) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. the company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. these 3d human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. in addition to numerous scientific publications, their technology has been featured in the wall street journal, time magazine, the economist, and other outlets. organovo is changing the shape of medical research and practice.
Organovo Inc executives and other stock owners filed with the SEC include: